• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 6
  3. Author

Online ISSN: 2515-8260

Volume9, Issue6

To Compare the Efficacy of Bolus Administration of Intravenous Dexmedetomidine 1 Microgram/Kg with Intravenous Esmolol 1.5 Mg/Kg in Attenuating the Cardiovascular Stress Response Accompanying Laryngoscopy and Endotracheal Intubation.

    Dr. Anantu Kumar, Dr. Nidhi Arun, Dr. Vinod Kumar Verma

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 6, Pages 1649-1656

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Laryngoscopy and intubation induce huge spectrum of stress responses such as tachycardia and hypertension. Those are in association with the surge of plasma adrenaline concentration following intubation. This study was performed to compare the efficacy of an accurate bolus dose of esmolol and bolus dose of dexmedetomidine in attenuating the pressor response to laryngoscopy and endotracheal intubation in general anaesthesia.
Materials and Methods: Randomised, comparative and double blinded study in which 30 patients were recruited in both the groups, Group D received injection Dexmedetomidine and Group Ereceived injection Esmolol assesment done for change in Heart rate, Systolic, Diastolic and mean blood pressurewith any adverse effects.
Results and Observations: Heart rate, SBP, DBP and MAP was lower in Group D as compared to Group E. No patients in either group required treatment for bradycardia and hypotension. No other adverse effects were noted in any patient.
Conclusion: Dexmedetomidine is effective in attenuating hemodynamic response to laryngoscopy and tracheal intubation without any side effect.
Keywords:
  • PDF (253 K)
  • XML
(2022). To Compare the Efficacy of Bolus Administration of Intravenous Dexmedetomidine 1 Microgram/Kg with Intravenous Esmolol 1.5 Mg/Kg in Attenuating the Cardiovascular Stress Response Accompanying Laryngoscopy and Endotracheal Intubation.. European Journal of Molecular & Clinical Medicine, 9(6), 1649-1656.
Dr. Anantu Kumar, Dr. Nidhi Arun, Dr. Vinod Kumar Verma. "To Compare the Efficacy of Bolus Administration of Intravenous Dexmedetomidine 1 Microgram/Kg with Intravenous Esmolol 1.5 Mg/Kg in Attenuating the Cardiovascular Stress Response Accompanying Laryngoscopy and Endotracheal Intubation.". European Journal of Molecular & Clinical Medicine, 9, 6, 2022, 1649-1656.
(2022). 'To Compare the Efficacy of Bolus Administration of Intravenous Dexmedetomidine 1 Microgram/Kg with Intravenous Esmolol 1.5 Mg/Kg in Attenuating the Cardiovascular Stress Response Accompanying Laryngoscopy and Endotracheal Intubation.', European Journal of Molecular & Clinical Medicine, 9(6), pp. 1649-1656.
To Compare the Efficacy of Bolus Administration of Intravenous Dexmedetomidine 1 Microgram/Kg with Intravenous Esmolol 1.5 Mg/Kg in Attenuating the Cardiovascular Stress Response Accompanying Laryngoscopy and Endotracheal Intubation.. European Journal of Molecular & Clinical Medicine, 2022; 9(6): 1649-1656.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 41
  • PDF Download: 112
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus